The fund, located in the United States, focuses on investing in startups in the therapeutics and pharmaceutical sectors. It typically invests between $100-500 million in each startup and has a preference for rounds with 5-6 participants. While the fund has a lower exit rate compared to other companies, it remains active and is involved in 2-6 deals per year. Some of its notable portfolio startups include Omada Health, Expansion Therapeutics, and Evidation Health.